5-Tridecanone,13-[(2R,3R,4S,5R)-3-(b-D-glucopyranosyloxy)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-hydroxy- (190317-46-5)

Identification
Name:	5-Tridecanone,13-[(2R,3R,4S,5R)-3-(b-D-glucopyranosyloxy)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-hydroxy-
Synonyms:	BroussonetineB
CAS:	190317-46-5
Molecular Formula:	C24H45 N O10
Molecular Weight:	0
InChI:	InChI=1/C24H45NO10/c26-12-8-7-10-15(29)9-5-3-1-2-4-6-11-16-23(19(30)17(13-27)25-16)35-24-22(33)21(32)20(31)18(14-28)34-24/h16-28,30-33H,1-14H2/t16?,17-,18-,19+,20-,21+,22-,23-,24+/m1/s1
Molecular Structure:
Properties
Flash Point:	414.2°C
Boiling Point:	761.2°C at 760 mmHg
Density:	1.3g/cm³
Refractive index:	1.568
Flash Point:	414.2°C
Safety Data

Other Product

5-Tridecanone,13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-(b-D-glucopyranosyloxy)-13-hydroxy-,(13R)-
4-Tridecanone,13-[(2R,3R,4S,5R)-1-ethyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-hydroxy-
5-Tridecanone,13-[(2R,3R,4R,5R)-1-ethyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-hydroxy-
4-Tridecanone, 13-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1,13-dihydroxy-, (13R)-
5-Tridecanone, 13-(3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1-hydroxy-, (2R-(2alpha,3beta,4beta,5beta))-
5-Tridecanone,13-[(2R,3R,4R,5R)-1-ethyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1,13-dihydroxy-, (13R)-
2H-Pyran-4-acetic acid,3-ethylidene-2-(b-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-,[(1S,2R,3R,5R)-5-[(1R)-2-[[[(2S,3E,4S)-3-ethylidene-2-(b-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetyl]oxy]-1-(hydroxymethyl)ethyl]-3-hydroxy-2-methylcyclopentyl]methylester, (2S,3E,4S)- (9CI)
2H-Pyran-4-acetic acid,3-ethylidene-2-(b-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-,[(1S,2R,3R,5R)-5-[(1S)-2-[[[(2S,3E,4S)-3-ethylidene-2-(b-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetyl]oxy]-1-(hydroxymethyl)ethyl]-3-hydroxy-2-methylcyclopentyl]methylester, (2S,3E,4S)- (9CI)
(3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-(13-hydroxy-10-oxotridecyl)pyrrolidin-3-yl beta-D-glucopyranoside
7H-Pyrazolo[4,3-d]pyrimidin-7-one,1,6-dihydro-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-
1H-Pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione,3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-
2,4(1H,3H)-Pyrimidinedione,5-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1-methyl-
3-Buten-2-one,4-[(2R,4S)-4-(b-D-glucopyranosyloxy)-2-hydroxy-2,6,6-trimethylcyclohexylidene]-,(3R)-
3-Buten-2-one,4-[(2R,4S)-2-(b-D-glucopyranosyloxy)-4-hydroxy-2,6,6-trimethylcyclohexylidene]-,(3R)-
4H-Pyrrolo[3,2-d]pyrimidin-4-one,3,5-dihydro-7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-
1H-Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione,7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-
2H-Pyran-4-acetic acid,3-ethylidene-2-(â-Dglucopyranosyloxy)- 3,4-dihydro-5-(methoxycarbonyl)-,[3-[[[(2S,3E,4S)-3-ethylidene-2- (â-D-glucopyranosyloxy)-3,4-dihydro-5- (methoxycarbonyl)-2H-pyran-4-yl]acetyl]oxy]- 5-[(1S,2R,3R,5R)-2-hydroxy-1-(hydroxymethyl) ethyl]-2-methylcyclopentyl]methyl ester,(2S,3E,4S)-
2,4(1H,3H)-Pyrimidinedione,5-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-
7H-Pyrazolo[4,3-d]pyrimidin-7-one,5-amino-1,6-dihydro-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-
4H-Pyrrolo[3,2-d]pyrimidin-4-one,2-amino-3,5-dihydro-7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-,hydrochloride (1:1)